Federal contractor · CLEVELAND, OH

HAIMA THERAPEUTICS LLC

No contract obligations recorded for HAIMA THERAPEUTICS LLC in FY2026. Since FY2018: $1.7M. It also received $1.5M in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
JKZPL4NA9V21
Small businessWoman-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 100KFY2018
  2. 1.6MFY2020
  3. 0FY2021
  4. 17.5KFY2022

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for HAIMA THERAPEUTICS LLC in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

HAIMA THERAPEUTICS LLC received $1.5M in federal assistance in FY2026, on 4 actions (1 new awards), +52% vs FY2025. Its largest program was 93.837 · Cardiovascular Diseases Research ($1.5M).

Assistance · FY2026
$1.5M
New awards
1
Actions
4
Since FY2021
$4.9M

Assistance by fiscal year

  1. 199.9KFY2021
  2. 0FY2022
  3. 1.1MFY2023
  4. 1.1MFY2024
  5. 994.7KFY2025
  6. 1.5MFY2026

By type

  1. Grants$1.5M100%

Top programs

  1. 93.837 · Cardiovascular Diseases Research$1.5M100%

Awarding agencies

  1. National Institutes of Health$1.5M100%
    Department of Health and Human Services

Largest awards

  1. SYNTHOPLATE: INTRAVENOUS HEMOSTATIC NANOTECHNOLOGY TO MITIGATE BLEEDING IN THROMBOCYTOPENIA - PROJECT SUMMARY/ABSTRACT THE NORMAL PLATELET…$2.1M
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Jun 1, 2023 – Apr 16, 2026· R44HL145948
  2. A NOVEL PLATELET-INSPIRED NANOTECHNOLOGY TO RESTORE HEMOSTASIS IN PATIENTS ON ANTIPLATELET AGENTS - PROJECT SUMMARY/ABSTRACT ANTIPLATELET…$2M
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Jul 11, 2025 – Aug 14, 2026· R44HL180258
  3. COMMERCIALIZATION STRATEGY FOR AN INTRAVENOUS HEMOSTATIC NANOTECHNOLOGY FOR BLEEDING MANAGEMENT - PROJECT SUMMARY/ABSTRACT MILLIONS OF…$500K
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Sep 17, 2026 – Sep 17, 2026· SB1HL184353

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

No subawards reported as a prime in FY2026.

As a sub-recipient: who pays it · FY2026

  • Sub-grants: $238K (1 subaward)

1 prime

  1. APPLIED RESEARCH INSTITUTE INC$238K100%
    BLOOMINGTON, IN · 1 subaward

By fiscal year

  • FY2021: $0 paid out · $735K received
  • FY2026: $0 paid out · $238K received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

No subawards reported to other companies.

Primes that pay it

2 companies · $973K reported

  1. CASE WESTERN RESERVE UNIVERSITY$735K
    CLEVELAND, OH · 1 subaward
  2. APPLIED RESEARCH INSTITUTE INC$238K
    BLOOMINGTON, IN · 1 subaward

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from 2021.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.